Over the last 7 days, the United States market has remained flat, yet it has seen a 20% increase over the past year with earnings projected to grow by 19% annually in the coming years. In this context, identifying stocks that are potentially undervalued can be an advantageous strategy for investors looking to capitalize on future growth opportunities while benefiting from current market conditions.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Pattern Group (PTRN)	$24.45	$47.85	48.9%
Mobileye Global (MBLY)	$8.30	$16.34	49.2%
HawkEye 360 (HAWK)	$21.70	$42.08	48.4%
Gold Royalty (GROY)	$2.75	$5.36	48.7%
Genuine Parts (GPC)	$117.18	$225.62	48.1%
DLocal (DLO)	$12.85	$24.57	47.7%
Dime Commercial Bancshares (DCOM)	$40.49	$80.97	50%
Capital One Financial (COF)	$202.28	$387.37	47.8%
Bloomin' Brands (BLMN)	$9.16	$17.48	47.6%
Beacon Financial (BBT)	$30.91	$60.40	48.8%

Let's explore several standout options from the results in the screener.

Natera (NTRA)

Overview: Natera, Inc. is a diagnostics company that develops and commercializes molecular testing services globally, with a market cap of approximately $37.51 billion.

Operations: The company generates revenue of approximately $2.50 billion from its molecular testing services worldwide.

Estimated Discount To Fair Value: 45.1%

Natera is trading at US$272.31, significantly below its estimated future cash flow value of US$496.41, suggesting it may be undervalued based on discounted cash flows. Despite recent insider selling, the company is expected to become profitable within three years with earnings growth projected at 58.05% annually. Recent strategic partnerships and regulatory approvals bolster its position in personalized cancer care and transplant monitoring, potentially enhancing long-term revenue streams and operational scale.

Pattern Group (PTRN)

Overview: Pattern Group Inc. is an e-commerce accelerator utilizing proprietary technology and on-demand expertise to aid consumer brands in navigating e-commerce marketplaces both in the United States and internationally, with a market cap of $4.05 billion.

Operations: The company's revenue segment is primarily from Online Retailers, amounting to $2.73 billion.

Estimated Discount To Fair Value: 48.9%

Pattern Group is trading at US$24.45, significantly below its estimated future cash flow value of US$47.85, highlighting potential undervaluation based on discounted cash flows. Recent inclusion in multiple Russell indexes could enhance visibility and investor interest. The company completed a US$152 million equity offering to support growth initiatives like Pattern Intelligence (Pi), an AI-powered ecommerce tool. Projected revenue growth of 18.5% annually outpaces the broader market, with profitability expected within three years.

AbbVie (ABBV)

Overview: AbbVie Inc. is a research-based biopharmaceutical company involved in the research, development, manufacturing, commercialization, and sale of medicines and therapies globally, with a market cap of approximately $447.62 billion.

Operations: The company's revenue primarily comes from its Innovative Medicines and Therapies segment, which generated $62.82 billion.

Estimated Discount To Fair Value: 41.5%

AbbVie, trading at US$254.31, is notably undervalued relative to its estimated future cash flow value of US$434.69. Despite high debt levels and a dividend not fully covered by earnings, AbbVie's forecasted annual profit growth of 26.7% outpaces the broader U.S. market's 18.6%. Recent positive trial results for treatments like epcoritamab in lymphoma and ongoing regulatory advancements in Europe could bolster future revenue streams despite slower-than-market revenue growth projections of 6.4% annually.

Where To Now?

• Investigate our full lineup of 135 Undervalued US Stocks Based On Cash Flows right here.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.